News Focus
News Focus
icon url

Amatuer17

07/06/18 10:15 AM

#156211 RE: Batermere #156210

In reality - so the approval to start the trial is announced - great - what next?

1. When will be 1st dosing?
2. What is the timeline that co announces as primary completion date on trial details? It will not be before Q2-2020 at the minimum
3. What is the funding model and how much dilution will come?

Once you answer the questions- many investors will be - OK see you after 1 1/2 years and we will get opportunity to buy the shares at same price.

So unless company announces a partnership, SP will stay below $5 for long time
icon url

LakeshoreLeo1953

07/06/18 10:20 AM

#156213 RE: Batermere #156210

Would have thought at a minimum the follow up would be
CRO announcement and more than ONE somewhat obscure web
page soliciting enrollment.

I will however bite the bullet and if need be (I hate this term)
cost average down if this does sink to my $2.93 math target.

Not my preference, but as Davey Jones once said:

"Disappointment haunted all of my dreams"